Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection.

Authors

Mark A Marzinke
William Clarke
Lei Wang
Vanessa Cummings
Ting-Yuan Liu
Manya Magnus, George Washington University
+13 additional authors

Document Type

Journal Article

Publication Date

1-1-2014

Journal

Clinical Infectious Diseases

Volume

58

Issue

1

Inclusive Pages

117-120

DOI

10.1093/cid/cit672

Keywords

Anti-Retroviral Agents--blood; HIV Infections--diagnosis; HIV Infections--drug therapy

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Marzinke, M., Clarke, W., Wang, L., Cummings, V., Liu, T., Magnus, M., & +13 additional authors (2014). Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection.. Clinical Infectious Diseases, 58 (1). http://dx.doi.org/10.1093/cid/cit672

Peer Reviewed

1

Open Access

1